K. Arvanitidis

Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.

V. Manolopoulos, G. Ragia, A. Tavridou, 2009, Pharmacogenomics.

Genetic polymorphisms of drug‐metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population

V. Manolopoulos, G. Ragia, A. Tavridou, 2007, Fundamental & clinical pharmacology.

The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians

V. Manolopoulos, A. Tavridou, K. Arvanitidis, 2008, Pharmacogenetics and genomics.

Thr54 allele of fatty-acid binding protein 2 gene is associated with obesity but not type 2 diabetes mellitus in a Caucasian population.

V. Manolopoulos, G. Ragia, A. Tavridou, 2009, Diabetes research and clinical practice.

Renin-angiotensin-aldosterone system gene polymorphisms in coronary artery bypass graft surgery patients

S. Kanoni, G. Dedoussis, V. Manolopoulos, 2010, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Endothelial nitric oxide synthase gene polymorphisms -786T >C and 894G >T in coronary artery bypass graft surgery patients

S. Kanoni, G. Dedoussis, V. Manolopoulos, 2010, Human Genomics.

The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes.

V. Manolopoulos, A. Tavridou, K. Arvanitidis, 2010, Clinica chimica acta; international journal of clinical chemistry.